Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis.
about
Magnitude of the disease burden from neurocysticercosis in a developing countryTaenia solium cysticercosisImmunology of Taenia solium taeniasis and human cysticercosisConservative management of neurocysticercosis in a patient with hematopoietic stem cell transplantation: a case report and reviewUnder seize: neurocysticercosis in an immigrant woman and review of a growing neglected diseaseExtraparenchymal (Racemose) Neurocysticercosis and Its Multitude Manifestations: A Comprehensive ReviewResolution of arterial stenosis in a patient with periarterial neurocysticercosis treated with oral prednisoneSerodiagnosis of human cysticercosis by using antigens from vesicular fluid of Taenia crassiceps cysticerciA Classic Case of Subcutaneous Cysticercosis: A Rare Case with Sonological Findings and Review of Literature.Accuracy of serological testing for the diagnosis of prevalent neurocysticercosis in outpatients with epilepsy, Eastern Cape Province, South Africa.Neurocysticercosis.Cysticercosis and epilepsy: a critical review.Taenia solium cysticercosis hotspots surrounding tapeworm carriers: clustering on human seroprevalence but not on seizures.Neurocysticercosis in children.Neglected parasitic infections in the United States: cysticercosis.Development and evaluation of a magnetic immunochromatographic test to detect Taenia solium, which causes taeniasis and neurocysticercosis in humans.Cysticercosis and epilepsy in rural Tanzania: a community-based case-control and imaging study.Cysticercosis immunodiagnosis using 18- and 14-kilodalton proteins from Taenia crassiceps cysticercus antigens obtained by immunoaffinity chromatographyEpidemiology of taeniosis/cysticercosis in Europe, a systematic review: Western Europe.A cross-sectional study of people with epilepsy and neurocysticercosis in Tanzania: clinical characteristics and diagnostic approachesSpecific Taenia crassiceps and Taenia solium antigenic peptides for neurocysticercosis immunodiagnosis using serum samples.Intraventricular neurocysticercosis: a review of current status and management issues.Laboratory diagnosis of human neurocysticercosis: double-blind comparison of enzyme-linked immunosorbent assay and electroimmunotransfer blot assaySolitary cysticercus granuloma.Human neurocysticercosis: comparison of different diagnostic tests using cerebrospinal fluid.Further characterization of Tsol-p27 as a diagnostic antigen in sub-Saharan Africa.Serologic diagnosis of human Taenia solium cysticercosis by using recombinant and synthetic antigens in QuickELISA™.Diagnosis and treatment of neurocysticercosis.High Prevalence of Asymptomatic Neurocysticercosis in an Endemic Rural Community in PeruSuccessful Antiparasitic Treatment for Cysticercosis is Associated with a Fast and Marked Reduction of Circulating Antigen Levels in a Naturally Infected Pig Model.Neurologic parasitic infections in immigrants and travelers.Comparative evaluation of purified Taenia solium glycoproteins and crude metacestode extracts by immunoblotting for the serodiagnosis of human T. solium cysticercosisContribution of immunodiagnostic tests to epidemiological/intervention studies of cysticercosis/taeniosis in Mexico.Oral Cysticercosis in a Pediatric Patient: A Rare Case Report with Review.Solitary neurocysticercosis case caused by Asian genotype of Taenia solium confirmed by mitochondrial DNA analysis.High prevalence of cysticercosis in people with epilepsy in southern Rwanda.Neurocysticercosis in radiographically imaged seizure patients in U.S. emergency departmentsHuman cysticercosis and Indian scenario: a review.Association between Taenia solium infection and HIV/AIDS in northern Tanzania: a matched cross sectional-studyRecombinant protein- and synthetic peptide-based immunoblot test for diagnosis of neurocysticercosis.
P2860
Q24599487-8B984A7D-53D0-4CDB-8B57-8128CD87ECD3Q24630431-34390B10-DBEF-4013-B703-4BC55F201120Q26864296-340C9489-9574-4643-A20A-602152B599BDQ27015925-FED6DC43-9B40-4484-BD42-F632229FF270Q28082720-85D825C9-0F12-4CF4-B908-6B01CFCEE75BQ28083769-FA373611-6337-43A6-BFA6-4D6B48ADF29AQ28212175-D5015600-5C1C-4A2D-A67A-4476D87E41E7Q28362954-1A4105C6-4DBD-4A5F-B28B-2B5D898ED9E2Q30371867-5A08C777-9B60-481A-B3A8-6F95BD096DB4Q30975304-A7E34E90-19CC-4EBB-B5E2-67CCF2A24E23Q31983351-A4947953-0F0B-4F8E-8CAC-79472D938CD9Q31997730-68891939-0047-44D1-8466-51F930BEF38CQ33403182-1219345E-02B6-4DA2-88CA-2075F7B5B7A6Q33452052-6012A2E0-4DD8-4A45-A958-A5BDDB8650B8Q33588459-A2C2A7F1-2E0E-4350-9F17-E751A4FDEB89Q33768704-9F929AED-2600-4BAB-8566-029618002F0CQ33870143-3B7CF7FF-00D2-4B8D-B093-CAC7CD0B2DD0Q33885021-0A970A60-96D8-437A-AF04-D52446B8A7ACQ33923011-04C61106-6C8E-4D63-BF05-2F97A93D02B1Q33930522-A478F56A-F127-49DB-8040-1A561315D039Q33964902-68E2E10E-7E48-4DEB-8DCC-7D4269F9DE2AQ34101071-EF7264D1-48BE-40E0-A014-9B53343B66E0Q34197320-6A48FAD0-55AC-4E78-BC47-8A756FDE88F0Q34306018-FF8022C2-26AD-42D2-886E-2023C2BFE302Q34487432-EDD72FC4-FB2D-4ADA-9245-EB68F9839B6DQ34639842-760874DF-7A14-41EB-93F6-B93D6F0B0844Q34707819-D02B1B9B-437F-4963-B236-23994367C247Q35953198-A5CBE2D5-32E1-468B-8868-94AE4B8E6CBDQ36227972-A729619D-D1C7-47AD-9411-23C1757AEAD3Q36359310-CBE65F22-33D2-4CC3-959F-E938B9EB90BDQ36415869-F0C303EB-9AC6-4E87-9A57-58EFE911A743Q36883364-70B33511-626C-4462-9E6A-2257104D61F2Q37016251-48579096-342F-4BD6-B162-317029A29D82Q37040019-70EBDB9A-F4C7-48E8-8791-EAC12562E148Q37157880-330DDFEE-21E7-47E7-B84D-E443FE7998F8Q37308692-E49A70EE-F86D-4ABB-AFAF-542C916642FBQ37334367-3CC890E2-ADCA-4EEC-937A-52BC3CCE2912Q37390243-409E0941-5425-4F9C-976D-490FDCA99167Q37460441-57ACAE88-C445-46F8-A795-BAF9116B1EBAQ37713682-CA96FB79-2B9B-4466-A003-AC8B677059AC
P2860
Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Clinical evaluation of the cys ...... ients with neurocysticercosis.
@en
Clinical evaluation of the cys ...... ients with neurocysticercosis.
@nl
type
label
Clinical evaluation of the cys ...... ients with neurocysticercosis.
@en
Clinical evaluation of the cys ...... ients with neurocysticercosis.
@nl
prefLabel
Clinical evaluation of the cys ...... ients with neurocysticercosis.
@en
Clinical evaluation of the cys ...... ients with neurocysticercosis.
@nl
P2093
P921
P356
P1476
Clinical evaluation of the cys ...... ients with neurocysticercosis.
@en
P2093
Pilcher JB
Schantz PM
P304
P356
10.1093/INFDIS/164.5.1007
P407
P577
1991-11-01T00:00:00Z